(43 days)
Not Found
No
The document describes a standard pulse oximeter that measures and displays SpO2 and pulse rate. There is no mention of AI or ML in the device description, intended use, or performance studies. The device functions as a standalone unit with data transmission capabilities, which is not indicative of AI/ML processing.
No
The device is described as a pulse oximeter for measuring and displaying oxygen saturation and pulse rate, which are diagnostic/monitoring functions, not therapeutic interventions.
Yes
The device is described as measuring and displaying functional oxygen saturation and pulse rate, which are used to assess a patient's physiological state. Furthermore, it explicitly states it is for "spot checking and/or continuous monitoring," which are common activities in diagnostics.
No
The device description explicitly states it is a "photoelectric pulse oximeter device" and mentions an "LCD" for displaying data, indicating it includes hardware components beyond just software.
Based on the provided information, the PMP4 Oxy Pro digital pulse oximeter system is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to provide information about a person's health. These tests are performed outside the body (in vitro).
- PMP4 Oxy Pro Function: The PMP4 Oxy Pro measures functional oxygen saturation and pulse rate by using photoelectric technology applied to the patient's body (likely a finger or earlobe). This is a non-invasive measurement performed on the body, not on a sample taken from the body.
- Intended Use: The intended use describes measuring and displaying vital signs directly from the patient.
- Device Description: The description confirms it's a photoelectric device for self-testing and measuring levels in the blood and pulse rate directly.
Therefore, the PMP4 Oxy Pro falls under the category of a non-invasive medical device used for physiological monitoring, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The PMP4 Oxy Pro digital pulse oximeter system is intended for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult and pediatric patients in different settings:
- a) At hospitals, homes and alternate-sites as well as for EMS environment and for transport use.
- b) At remote locations, where patients can obtain, display and transmit their pulse oximeter vital signs data to a medical expert via a communication device, such as a PDA or a remote server.
The PMP4 Oxy Pro is indicated for spot checking and/or continuous monitoring.
Product codes (comma separated list FDA assigned to the subject device)
DQA
Device Description
The PMP4 Oxy Pro is a photoelectric pulse oximeter device to be used for self testing upon prescription of an authorized health care provider. Specifically, it is designed for patients who wish to measure the oxygen saturation levels in the blood and pulse rate.
The PMP4 OxyPro is manually activated by the patient. It functions as a stand-alone device as patient can see "real time" data on its LCD. In addition, the PMP4 OxyPro enables transmission of real time data to the patient's PMP4 PDA or compatible generic PDA phone or personal computer supporting Bluetooth (BT) protocol.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult and pediatric patients
Intended User / Care Setting
hospitals, homes and alternate-sites as well as for EMS environment and for transport use. remote locations, where patients can obtain, display and transmit their pulse oximeter vital signs data to a medical expert
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The device biocompatibility was evaluated and found to be satisfactory.
The device Level of Concern criteria were evaluated and PMP4 Oxy Pro was characterized as a moderate level of concern system.
The system safety and risk analysis conducted for PMP4 Oxy Pro provided rigorous design and structural evaluation aimed at revealing potential failures or possible system flaws which could directly or indirectly affect the patient.
PMP4 Oxy Pro constitutes a safe and reliable means for measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult and pediatric patients. Its material composition and operation present no adverse health effect or safety risks to patients when used as intended.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
DEC 29 2004
CARD GUARD
Scientific Survival Ltd
PMP4 Oxy Pro
510(k) Premarket Notification
Chapter 16
Summary of Safety and Effectiveness
1
| | PMP4 Oxy Pro
510(k) Summary of Safety and Effectiveness |
|-----------------|--------------------------------------------------------------------------------------------------------|
| Submitter: | Card Guard Scientific Survival Ltd., |
| | 2 Pekeris St. P.O.B. 527
Rehovot 76100, Israel |
| | Tel: 972-8-9484000 |
| | Fax: 972-8-9484044 |
| Contact Person: | Boris Aradovsky,
VP QA and Regulatory Affairs
Tel: 972-8-9484000
E-mail: borisa@cardguard.com |
| Date Prepared: | October 12, 2004 |
Definition 1.
The PMP4 Oxy Pro is a photoelectric pulse oximeter device to be used for self testing upon prescription of an authorized health care provider. Specifically, it is designed for patients who wish to measure the oxygen saturation levels in the blood and pulse rate.
The PMP4 OxyPro is manually activated by the patient. It functions as a stand-alone device as patient can see "real time" data on its LCD. In addition, the PMP4 OxyPro enables transmission of real time data to the patient's PMP4 PDA or compatible generic PDA phone or personal computer supporting Bluetooth (BT) protocol.
2. Intended Use
The PMP4 Oxy Pro digital pulse oximeter system is intended for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult and pediatric patients in different settings:
- a) At hospitals, homes and alternate-sites as well as for EMS environment and for transport use.
- b) At remote locations, where patients can obtain, display and transmit their pulse oximeter vital signs data to a medical expert via a communication device, such as a PDA or a remote server.
The PMP4 Oxy Pro is indicated for spot checking and/or continuous monitoring.
UNCONTROLLED 1 1 NOV 2004 COPY
| This document contains proprietary information of
| CARD GUARD Scientific Survival Ltd. | Document No. | Rev. | Page | of |
|---|---|---|---|---|
| --- | 01 | 1 | 4 |
2
3. Applicable Standards, Regulations, Guidances
PMP4 Oxy Pro meets the requirements of the following Standards, Regulations and Guidances:
- . ISO 14971:2000 , Medical devices - Application of risk management to medical devices
- . IEC 1025: 1990 Fault tree analysis (FTA)
- IEC 801-1, 1984, General Introduction .
- . IEC 601-1-1, 1996, Safety Requirements for Medical Electrical Systems
- IEC 601-1-2, 2001, Part 2: Electromagnetic compatibility-Requirements and Tests .
- IEC 601-1-4, 1996, Part 1-4, Programmable Electrical Medical Systems
- IEC 801-2, 1991, Electrostatic Discharge Requirements' .
- IEC 801-3, 1992, Immunity to Radiated Radiofrequency electromagnetic fields .
- . IEC 801-4, 1988, Electrical Fast Transient Burst Requirements
- . CISPR 11 1990 Limits and Methods of Measurement of Electromagnetic Disturbance Characteristics of Industrial, Scientific and Medical (ISM) Radio frequency Equipment 2nd Edition
- Reviewer Guidance for Computer Controlled Medical Devices, FDA Aug 29, 1991 .
- ISO 13485 (2003), Medical Devices Quality Management Systems .
- ISO 9001:2000, Quality Management Systems Requirements .
- ISO 10993:2003, parts 1, 5, 10 Biological evaluation of medical devices. . Evaluation and testing MIL-STD 810E, product environmental testing
- FDA's New 510(k) Paradigm, Alternate Approaches to Demonstrating Substantial . equivalence in Premarket Notifications Final Guidance, CDRH, March 20, 1998.
- 21 CFR part 820 subchapter H medical devices , quality system regulations .
4. Features
- . Two control buttons
- . Transmission via Bluetooth an IR (future optional)
- The device is internally-powered with applied parts of type CF, suitable for . continuous operation.
- . Low Battery detection.
| This document contains proprietary information of
| CARD GUARD Scientific Survival Ltd. | Document No. | Rev. | Page | of |
|---|---|---|---|---|
| --- | 01 | 2 | 4 |
3
Image /page/3/Figure/0 description: The image shows the text "CARD GUARD" in bold, black letters. Below this text is the phrase "Scientific Survival LTD" in a smaller, lighter font. To the right of the text, there is a stylized graphic resembling an electrocardiogram (ECG) waveform, which is commonly associated with heart monitoring.
5. User Interface
The PMP4 Oxy Pro user interface incorporates the following controls and signals:
- . On/off control button
- . Low battery warning
6. Substantial Equivalence
The substantially equivalence to the following predicate devices is claimed:
| Nonin
Avant®
model
4000 | Digital Pulse Oximetry System | K041156 | Decision Date
06/09/2004 |
| ---------------------------------- | ------------------------------- | --------- | ----------------------------- |
|---|
The Nonin Avant® 4000 was cleared as a prescription device on 06/09/04.
The PMP4 Oxy Pro, subject of this application, is substantially equivalent to the predicate device.
- . Intended use:
Both devices are indicated for spot checking by patients and/or continuous monitoring. Both devices are digital pulse oximeter systems intended for measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. They both intended for adults and pediatrics.
The correlation between the comparable parameters and features of the devices, for the purpose of proving their substantial equivalency is herby provided in the comparison table on chapter 7.
7. Design Controls and Hazard Analysis
The Card Guard's product design procedure, and QA and QC policy, formalize the design and production process and assure that all respective requirements are met. In the framework of the Design Controls laboratory testing were conducted to verify and validate the PMP4 Oxy Pro compliance with all design specifications.
The device biocompatibility was evaluated and found to be satisfactory.
The device Level of Concern criteria were evaluated and PMP4 Oxy Pro was characterized as a moderate level of concern system.
| This document contains proprietary information of
| CARD GUARD Scientific Survival td. | Document No. | Rev. | Page | of |
|---|---|---|---|---|
| - | 01 | 3 | 4 |
4
Image /page/4/Picture/0 description: The image shows the logo for Card Guard Scientific Survival LTD. The words "CARD GUARD" are in bold, black letters, with a line underneath. Below the line, the words "Scientific Survival LTD" are in a smaller, lighter font. To the right of the text is a graphic that resembles an EKG readout.
The system safety and risk analysis conducted for PMP4 Oxy Pro provided rigorous design and structural evaluation aimed at revealing potential failures or possible system flaws which could directly or indirectly affect the patient.
8. Conclusions
1.4
PMP4 Oxy Pro constitutes a safe and reliable means for measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult and pediatric patients. Its material composition and operation present no adverse health effect or safety risks to patients when used as intended.
| This document contains proprietary information of | ||||
|---|---|---|---|---|
| Document No. | Rev. | Page | ||
| CARD GUARD Scientific Survival Ltd. | ||||
5
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 2 9 2004
Mr. Boris Aradovsky Vice President Quality Assurance and Regulatory Affairs Card Guard Scientific Survival, Limited 2 Pekeris Street P.O.B 527 Rehovot, 76100 ISRAEL
Re: K043162
Trade/Device Name: PMP4 Oxy Pro Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: November 16, 2004 Received: November 16, 2004
Dear Mr. Aradovsky:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
6
Page 2 - Mr. Aradovsky
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours,
Chu Lin, Ph.D.
hiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number: K043162
Device Name: PMP4 Oxy Pro
Indications For Use:
The PMP4 Oxy Pro digital pulse oximeter system is intended for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult and pediatric patients in different settings:
- a) At hospitals, homes and alternate-sites as well as for EMS environment and for transport use.
- b) At remote locations, where patients can obtain, display and transmit their pulse oximeter vital signs data to a medical expert via a communication device, such as a PDA or a remote server.
Prescription Use ___ √______ AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON NOTHERPAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
e
(Division Sign-Off)
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
Division of Anesthesiology, General Hospital,
Infection Control, Dental Devices
510(k) Number: K043162